Laura Woods is committed to patient safety issues. She enjoys breaking news about FDA recalls, sharing important events in pharmaceutical litigation, and reporting on favorable outcomes for victims of dangerous drugs and medical devices.
Boston Scientific has now won two transvaginal mesh lawsuits in Massachusetts state court. On August 29, following two days of deliberation, a Massachusetts jury returned a Obtryx product liability verdict in favor of the defendant. The state court judge presiding over the proceedings previously excluded... Read More
Johnson & Johnson has moved to dismiss a baby powder class action lawsuit recently filed against the corporation. The plaintiff, Barbara Mihalich, alleges that the talcum-based product may increase the risk of ovarian cancer when used on the genital areas. Mihalich filed her lawsuit in... Read More
Although Bayer has already paid more than $1.8 billion to settle Yasmin and Yaz lawsuits, the company reports that approximately 5,000 lawsuits are still pending in the court system. The company’s 2014 second-quarter financial report notes that Bayer has reached settlement agreements with more than... Read More
A Missouri federal judge has remanded a GranuFlo and NaturaLyte lawsuit to state court, citing a lack of complete diversity of citizenship, rejecting the defendants’ arguments that the nondiverse plaintiffs do not have a colorable claim. Judge Stephen M. Limbaugh Jr. also denied the defendants’... Read More
Covidien has announced the company will take a $180 million hit in the third quarter, to pay costs associated with transvaginal mesh lawsuits. In a July 11 report filed with the U.S. Securities and Exchange Commission, the medical device manufacturer discussed the situation. “Covidien currently is... Read More
A recent report highlights the link between Benicar and sprue-like enteropathy, emphasizing the importance of doctors being fully aware that the blood pressure medication may cause patients to experience chronic diarrhea and potentially suffer from permanent intestinal damage that is not Celiac disease. Celiac disease ─ otherwise... Read More
New research suggests that an increased risk of chronic kidney disease may be among the many Actos side effects. A recent study published in medical journal PLoS One suggests that the diabetes drug may be linked to chronic kidney disease. The study was conducted by... Read More
A Lafayette, Louisiana jury has ordered Takeda Pharmaceutical Co. and Eli Lilly Co. to pay a combined total of $9 billion in compensation for Actos side effects. While Takeda was ordered to pay $6 billion and their partner Eli Lilly was ordered to pay $3... Read More
